Skip to main content
. 2022 Mar 21;15(9):1713–1719. doi: 10.1093/ckj/sfac077

Table 3.

RAASi prescription pattern among patients who survived 90 days after the index hyperkalemia episode

RAASi Total, N = 8145 Received SPS/CPS prescription, N = 399 No SPS/CPS prescription, N = 7746 P-value
Discontinuation 1447 (17.77%) 71 (17.79%) 1376 (17.76%) 0.98
Continuation 6698 (82.23%) 328 (82.21%) 6370 (82.24%)
 Maximum dose 1467 (18.01%) 80 (20.05%) 1387 (17.91%) 0.53
 Submaximal dose 5231 (64.22%) 248 (62.16%) 4983 (64.33%)

Data are presented as n (%).